HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Extrahepatic Bile Duct Cancer

Extrahepatic Bile Duct Cancer

Extrahepatic bile duct cancer, a rare and aggressive malignancy, arises from the bile ducts outside the liver. It presents challenges in diagnosis and treatment due to its often asymptomatic nature until advanced stages. Research efforts in understanding its pathogenesis and identifying biomarkers for early detection are crucial. Advances in imaging modalities and molecular profiling offer promising avenues for diagnosis and personalized treatment strategies. Additionally, exploring novel therapeutic targets, such as immunotherapy and targeted therapy, holds potential for improving outcomes in this challenging disease. Collaborative interdisciplinary research endeavors are essential to unravel the complexities of extrahepatic bile duct cancer and develop effective interventions to enhance patient prognosis and quality of life.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Committee Member - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp